Tam Anh General Hospital System and Stanford Institute for Microbiology and Epidemiology cooperate to promote the development of biomedical technology, drug discovery, application of artificial intelligence in health care, and implementation of clinical trials at Tam Anh Research Institute.
Signing ceremony of cooperation between Tam Anh Research Institute and Stanford Institute for Microbiology and Epidemiology
"This event is an important milestone in scientific research cooperation between Vietnam and the US. In particular, at this time, we believe that the positive results of the US President's visit to Vietnam will continue to create favorable conditions for scientific and medical cooperation to be supported to develop rapidly and successfully, bringing benefits to health care and medical examination and treatment for Vietnamese people" - Ms. Nguyen Thi Ngoc Dung, senior expert of the Center for Innovation, Ministry of Planning and Investment - affirmed.
The Stanford Institute for Microbiology and Infectious Diseases is a research institute of Stanford University, USA, focusing on the preclinical development of new therapeutic methods to combat diseases caused by viruses. In parallel, scientists also focus on developing new drugs to treat cancer, dengue fever, hepatitis, etc. Stanford University currently owns 1 of the 9 largest microbiology and infectious disease research laboratories in the US, where thousands of scientists in this field work, focusing on research on measures to prevent epidemics and infectious diseases.
In order to enhance the capacity of biological research technology in Vietnam to respond to infectious diseases, the Stanford University Institute for Microbiology and Epidemiology will support the Tam Anh Research Institute to build a modern laboratory system for clinical drug trials according to strict standards from Stanford. In addition, the two sides will work together to plan strategies and exchange knowledge between scientists to conduct comprehensive research on epidemics caused by viruses.
The cooperation agreement between Tam Anh Research Institute, Tam Anh General Hospital System and Stanford University's Institute of Microbiology and Epidemic Prevention will contribute to realizing the goal of sustainable healthcare , reducing the burden on the healthcare sector when responding to infectious diseases, and improving the domestic biopharmaceutical production capacity.
Professor Jeffrey S. Glenn, Director of the Stanford Institute for Microbiology and Epidemiology, visited Tam Anh General Hospital, Hanoi. Photo: Tam Anh General Hospital
Prof. Dr. Nguyen Van Tuan, Scientific Director of Tam Anh Research Institute, Tam Anh General Hospital System, said: "Immediately after the signing ceremony, we will join hands to soon carry out important projects such as diagnostic testing and treatment of hepatitis D; developing drugs to treat cancer related to immune mechanisms, drugs to treat dengue fever... In addition, we will strengthen training exchanges and professional cooperation between scientists of both sides in Vietnam and the US, further tightening cooperation in science, education, health and economy between the two countries".
At the ceremony, Tam Anh Research Institute and Stanford Institute for Microbiology and Epidemiology signed a cooperation agreement on four important research projects: Improving the capacity of biological research technology in Vietnam through the construction of a clinical trial system and modern research laboratories. Training on the exploitation of artificial intelligence (AI) for medical applications. Research on the development of new drugs to prevent dengue fever. Research on the rate of infection and screening of HDV hepatitis D virus in Vietnam.
During the cooperation, Stanford researchers will share and coordinate expertise with Tam Anh Research Institute. Tam Anh Research Institute, with its advantages in hospital system, modern equipment system for testing and research, will be an ideal place for scientists to conduct research, testing, and develop treatment drugs.
Representing the Stanford Institute for Microbiology and Epidemiology, Professor Jeffrey S. Glenn - Director - said: "If scientific inventions, innovations and creations from research labs are successful, they will bring great benefits to humanity. Bringing scientific research and clinical trials of new drugs to Vietnam will be a good opportunity for people to have early access to new and good treatment methods in the world."
Professor Jeffrey S. Glenn, Director of the Stanford Institute for Microbiology and Epidemiology (left) speaks at the cooperation signing ceremony. Photo: Tam Anh General Hospital
The selection of Tam Anh Research Institute for this important action cooperation by the Stanford Institute for Microbiology and Epidemiology shows the high appreciation of American scientists for Vietnam's scientific environment, human resource quality and infrastructure for modern research that fully meets the high criteria of the United States in this field.
The cooperation between the two units is expected to bring breakthrough results, significantly contributing to the development of medical capacity, bringing good values to the people.
Source
Comment (0)